GlassScriptPhysician profile
Hillary P Mayers
NPI 1417476201
$1,705.07
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $463 · 2022: $741 · 2023: $478 · 2024: $23.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $501.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $271.62 | 2021-2023 | Otezla, Repatha |
| Harmony Biosciences LLC | $191.20 | 2022-2023 | Wakix |
| Novo Nordisk INC | $167.76 | 2021-2023 | Rybelsus, Ozempic |
| Lilly USA, LLC | $156.54 | 2021-2023 | Jardiance, Mounjaro, Emgality |
| Astrazeneca Pharmaceuticals LP | $95.59 | 2022 | |
| Glaxosmithkline, LLC. | $85.40 | 2021-2023 | Trelegy Ellipta |
| Astellas Pharma US INC | $80.98 | 2023-2024 | Veozah |
| Biohaven Pharmaceutical Holding Company LTD. | $72.90 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.63 | 2021-2023 | Tradjenta |
| Takeda Pharmaceuticals U.S.A., INC. | $68.12 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $60.57 | 2021 | |
| Biogen, INC. | $48.80 | 2021 | |
| Pharmacosmos Therapeutics INC. | $45.93 | 2021 | |
| Pfizer INC. | $45.26 | 2023 | |
| Idorsia Pharmaceuticals US INC | $38.89 | 2023 | Quviviq |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $37.42 | 2021-2022 | |
| Organon LLC | $37.26 | 2022-2023 | Nexplanon |
| Dexcom, INC. | $34.74 | 2023 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.43 | 2022 | |
| Insulet Corporation | $19.51 | 2023 | Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $19.32 | 2023 | |
| Ironshore Pharmaceuticals INC. | $15.85 | 2022 | |
| Currax Pharmaceuticals LLC | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hillary Mayers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.